Genetically Modified Porcine-to-Human Cardiac Xenotransplantation
28 June 2022
| A 57-year-old man with nonischemic cardiomyopathy who was dependent on venoarterial extracorporeal membrane oxygenation (ECMO) and was not a candidate for standard therapeutics, including a traditional allograft, received a heart from a genetically modified pig source animal that had 10 individual gene edits. | |
| Sudden diastolic thickening and failure of the xenograft occurred on day 49 after transplantation, and life support was withdrawn on day 60. On autopsy, the xenograft was found to be edematous, having nearly doubled in weight. Histologic examination revealed scattered myocyte necrosis, interstitial edema, and red-cell extravasation, without evidence of microvascular thrombosis — findings that were not consistent with typical rejection. Studies are under way to identify the mechanisms responsible for these changes. (Funded by the University of Maryland Medical Center and School of Medicine.) | |
| Author(s) | Source |
| Griffith BP, Goerlich CE, Singh AK, Rothblatt M et al. | The New England Journal of Medicine, June 22, 2022, DOI: 10.1056/NEJMoa2201422 |
| This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. The content usually is shortened to make it understandable for many. Read the linked original text if you are interested. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register. | |
| Comments: n/a let us know |
|
Find NEWS and PUBLICATIONS here according to your interests or use the search box.
